{{Infobox Disease |
  Name           = Orbital lymphoma |
  Image          = Orbital lymphoma.png|
  Caption        = |
  DiseasesfsdgsdfDB     = |
  ICD10          =  |
  ICD9           = 202.8 |
  ICDO           = 9710–9719 |
  OMIM           = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
}}

'''Orbital lymphoma''' is common type of [[non-Hodgkin lymphoma]] that occurs near or on the eye. Common symptoms include decreased vision and [[uveitis]]. Orbital lymphoma can be diagnosed via a [[biopsy]] of the eye and is usually treated with [[Radiotherapy]] or with combination with [[chemotherapy]].

==Symptoms==

Primary visible symptoms of ocular lymphoma include [[proptosis]] and a visible mass in the eye. Other symptoms are due to [[mass effect (medicine)|mass effect]].

== Pathophysiology ==
Recent studies{{By whom|September 2011|date=September 2011}} have detected the presence of [[DNA|viral DNA]] in ocular lymphoma cells. This implies that pathogens play a role in ocular lymphoma. Other studies have found that the [[aging population]], the increasing number of [[immunosuppressive drugs]], and the [[AIDS epidemic]] have also contributed to the increased incidence of Non-Hodgkin lymphomas.

Ocular [[MALT lymphoma]]s may also be associated with [[Chlamydia psittaci]],<ref name=Rosado>{{cite journal|last=Rosado|first=MF|coauthors=Byrne GE, Jr; Ding, F; Fields, KA; Ruiz, P; Dubovy, SR; Walker, GR; Markoe, A; Lossos, IS|title=Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci|journal=Blood|date=2006 Jan 15|volume=107|issue=2|pages=467–72|pmid=16166588|url=http://bloodjournal.hematologylibrary.org/content/107/2/467.long|accessdate=1 December 2012|doi=10.1182/blood-2005-06-2332|pmc=1895606}}</ref><ref>{{cite journal|last=Chanudet|first=E|coauthors=Zhou, Y; Bacon, CM; Wotherspoon, AC; Müller-Hermelink, HK; Adam, P; Dong, HY; de Jong, D; Li, Y; Wei, R; Gong, X; Wu, Q; Ranaldi, R; Goteri, G; Pileri, SA; Ye, H; Hamoudi, RA; Liu, H; Radford, J; Du, MQ|title=Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions|journal=The Journal of pathology|date=2006 Jul|volume=209|issue=3|pages=344–51|doi=10.1002/path.1984|pmid=16583361|url=http://onlinelibrary.wiley.com/doi/10.1002/path.1984/abstract;jsessionid=18857C6AE5D37568C03088DC04B191E6.d04t04|accessdate=1 December 2012}}</ref> although whether or not this is the case is still debated.<ref name=Rosado />

[[Follicular lymphoma]], [[diffuse large B cell lymphoma]], [[mantle cell lymphoma]], [[B-cell chronic lymphocytic leukemia]], [[peripheral T-cell lymphoma]], and [[natural killer cell lymphoma]] have also been reported to affect the orbit.{{Citation needed|date=September 2011}}

== Epidemiology ==
55% of all [[lymphoma]] cases in adults and 10% in older patients is a form of ocular lymphoma.<ref>{{cite journal|last=Valvassori|first=GE|coauthors=Sabnis, SS; Mafee, RF; Brown, MS; Putterman, A|title=Imaging of orbital lymphoproliferative disorders|journal=Radiologic clinics of North America|year=1999|month=Jan|volume=37|issue=1|pages=135–50, x–xi|doi=10.1016/S0033-8389(05)70083-X|pmid=10026734}}</ref><ref>{{cite journal|last=Shields|first=Jerry A|coauthors=Shields, Carol L; Scartozzi, Richard|title=Survey of 1264 patients with orbital tumors and simulating lesions|journal=Ophthalmology|year=2004|month=May|volume=111|issue=5|pages=997–1008|doi=10.1016/j.ophtha.2003.01.002|pmid=15121380|url=http://www.aaojournal.org/article/S0161-6420(03)01495-7/abstract|accessdate=1 December 2012}}</ref>  In 2008, a prediction by the National Cancer Institute Surveillance, estimated that in 1,340 men and 1,050 women would be diagnosed with eye cancer and 240 people would die of the disease that year<ref>{{cite web| publisher=National Cancer Institute| title=Surveillance, Epidemiology, and End Results Cancer Fact Stat Sheet, Cancer of the Eye and Orbit| url=http://seer.cancer.gov/statfacts/html/eye.html| accessdate=2008}}</ref> Orbital lymphoma is more prevalent in Asia and Europe than in the United States.<ref>{{cite journal|last=Ohtsuka|first=Kenji|coauthors=Hashimoto, Masato; Suzuki, Yasuo|title=High incidence of orbital malignant lymphoma in Japanese patients|journal=American Journal of Ophthalmology|year=2004|month=Nov|volume=138|issue=5|pages=881–882|doi=10.1016/j.ajo.2004.05.069|pmid=15531337|url=http://www.ajo.com/article/S0002-9394(04)00650-6/abstract|accessdate=1 December 2012}}</ref><ref>{{cite journal|last=Shikishima|first=Keigo|coauthors=Kawai, Kazushige; Kitahara, Kenji|title=Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature|journal=Clinical and Experimental Ophthalmology|year=2006|month=April|volume=34|issue=3|pages=239–244|doi=10.1111/j.1442-9071.2006.01192.x|pmid=16671904}}</ref><ref>{{cite journal|last=Ko|first=YH|coauthors=Kim, CW; Park, CS; Jang, HK; Lee, SS; Kim, SH; Ree, HJ; Lee, JD; Kim, SW; Huh, JR|title=REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma|journal=Cancer|date=1998 Aug 15|volume=83|issue=4|pages=806–12|pmid=9708949|doi=10.1002/(SICI)1097-0142(19980815)83:4<806::AID-CNCR26>3.3.CO;2-8}}</ref><ref>{{cite journal|last=Seregard|first=S|coauthors=Sahlin, S|title=Panorama of orbital space-occupying lesions. The 24-year experience of a referral centre|journal=Acta ophthalmologica Scandinavica|date=1999 Feb|volume=77|issue=1|pages=91–8|pmid=10071158|doi=10.1034/j.1600-0420.1999.770121.x}}</ref> 

Although intraocular lymphoma is rare, the number of cases per year is rising, affecting mainly people in their seventies<ref>{{cite journal|last=Moslehi|first=R.|coauthors=Devesa, S. S.; Schairer, C.; Fraumeni, J. F.|title=Rapidly Increasing Incidence of Ocular Non-Hodgkin Lymphoma|journal=JNCI Journal of the National Cancer Institute|year=2006|month=July|volume=98|issue=13|pages=936–939|doi=10.1093/jnci/djj248|pmid=16818858|url=http://jnci.oxfordjournals.org/content/98/13/936.long|accessdate=1 December 2012}}</ref><ref>{{cite journal|last=Demirci|first=H|coauthors=Shields, CL; Shields, JA; Honavar, SG; Mercado, GJ; Tovilla, JC|title=Orbital tumors in the older adult population|journal=Ophthalmology|date=2002 Feb|volume=109|issue=2|pages=243–8|pmid=11825802|url=http://www.aaojournal.org/article/S0161-6420(01)00932-0/abstract|accessdate=1 December 2012|doi=10.1016/S0161-6420(01)00932-0}}</ref> and [[immunodeficiency|immunocompromised]] patients<ref>Burnier MN Jr, Stockl FA, Dolmetsch AM. Large B-cell lymphoma of the retina and CNS. Presented at the 1994 Annual Meeting of the Eastern Ophthalmic Pathology Society, Boston, Mass. October 1994.</ref><ref>{{cite journal|last=Schabet|first=M|title=Epidemiology of primary CNS lymphoma|journal=Journal of neuro-oncology|date=1999 Jul|volume=43|issue=3|pages=199–201|pmid=10563423|doi=10.1023/A:1006290032052}}</ref>  A recent study has shown that ocular lymphoma is more prevalent in women than men.<ref>{{cite journal|last=Ahmed|first=S|coauthors=Shahid, RK; Sison, CP; Fuchs, A; Mehrotra, B|title=Orbital lymphomas: a clinicopathologic study of a rare disease|journal=The American journal of the medical sciences|date=2006 Feb|volume=331|issue=2|pages=79–83|pmid=16479179|doi=10.1097/00000441-200602000-00013}}</ref> 

The survival rate is approximately 60% after 5 years.{{Citation needed|date=September 2011}}

==Types==
There are two types of ocular lymphomas: intraocular lymphomas and adnexal lymphomas. An intraocular lymphoma occurs within the eye, while an adnexal lymphoma occurs outside, but adjoined to the eye.

=== Intraocular lymphoma ===
There are two main types of intraocular lymphomas: primary central nervous system involvement (PCNSL) and primary central nervous system with ocular involvement (PCNSLO). The difference between PCNSL and PCNSLO is that PNSCL involves the [[central nervous system]], while PCNSLO doesn't. 56-86% of orbital lymphomas are classified PCNSL and 15-25% are classified PCNSLO.<ref>{{cite journal|last=Char|first=DH|coauthors=Ljung, BM; Miller, T; Phillips, T|title=Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management|journal=Ophthalmology|date=1988 May|volume=95|issue=5|pages=625–30|pmid=3050698}}</ref><ref>{{cite journal|last=Char|first=DH|coauthors=Margolis, L; Newman, AB|title=Ocular reticulum cell sarcoma|journal=American journal of ophthalmology|date=1981 Apr|volume=91|issue=4|pages=480–3|pmid=7013487}}</ref><ref>{{cite journal|last=Peterson|first=K|coauthors=Gordon, KB; Heinemann, MH; DeAngelis, LM|title=The clinical spectrum of ocular lymphoma|journal=Cancer|date=1993 Aug 1|volume=72|issue=3|pages=843–9|pmid=8334638|doi=10.1002/1097-0142(19930801)72:3<843::AID-CNCR2820720333>3.0.CO;2-#}}</ref><ref>{{cite journal|last=Freeman|first=LN|coauthors=Schachat, AP; Knox, DL; Michels, RG; Green, WR|title=Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma|journal=Ophthalmology|date=1987 Dec|volume=94|issue=12|pages=1631–9|pmid=3323986}}</ref> 

PCNSLO is common in people who are severely immunosuppressed. 

Symptoms of this form of ocular lymphoma include painless decreased vision, [[photophobia]], a red eye, and [[floater]]s. Diagnosis is difficult due to its gradual onset and the fact that the symptoms are the same as other diseases.

PCNSLO is usually [[Symmetry in biology#Bilateral symmetry|bilateral]], but sometimes grows unevenly. Like other [[metastasis|metastatic]] tumors of the eye, it is usually confined to the [[choroid]].<ref>{{cite journal|last=Chan|first=CC|coauthors=Buggage, RR; Nussenblatt, RB|title=Intraocular lymphoma|journal=Current opinion in ophthalmology|date=2002 Dec|volume=13|issue=6|pages=411–8|pmid=12441846|doi=10.1097/00055735-200212000-00012}}</ref> 

=== Orbital and adnexal lymphoma ===
{{Empty section|date=July 2011}}

== Treatment ==
[[Radiotherapy]] is the most effective treatment for local disease either as the sole treatment for low-grade lymphoma or in combination with [[chemotherapy]] for intermediate- and high-grade lymphoma.<ref>{{cite journal |title=Orbital lymphoma: Is it necessary to treat the entire orbit? |author=Pfeffer M R, Rabin T, Tsvang L, Goffman J, Rosen N, Symon Z |journal=International Journal of Radiation Oncology*Biology*Physics |year=2004 |month=october |volume=60 |issue=2 |pages=527–530 |doi= 10.1016/j.ijrobp.2004.03.039}}</ref><ref>{{cite book | title=Instant clinical diagnosis in ophthalmology: oculoplasty & reconstructive surgery | publisher=Jaypee Brothers Publishers, 2009 | author=Garg | pages=336 | isbn=978-81-8448-403-8}}</ref> Radiotherapy dose in range of 30-45 Gy administered in fractions are advised in treating the local orbital lymphomas<ref>{{cite book | title=Clinical oncology, Volume 1 | publisher=Wiley-Blackwell | author=Raymond E. Lenhard, Robert T. Osteen, Ted S. Gansler | pages=919 | isbn=978-0-944235-15-7}}</ref>

== References ==
{{Reflist}}

{{Eye tumors}}
{{Eye pathology}}

{{DEFAULTSORT:Orbital Lymphoma}}
[[Category:Oncology]]
[[Category:Ocular neoplasia]]
[[Category:Lymphoma]]
[[Category:Disorders of eyelid, lacrimal system and orbit]]